Skip to main content
Erschienen in: European Radiology 4/2017

23.08.2016 | Oncology

Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour

verfasst von: Yasuhisa Kurata, Aki Kido, Yusaku Moribata, Kyoko Kameyama, Yuki Himoto, Sachiko Minamiguchi, Ikuo Konishi, Kaori Togashi

Erschienen in: European Radiology | Ausgabe 4/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

To evaluate the diagnostic performance of quantitative values and MRI findings for differentiating seromucinous borderline tumours (SMBTs) from endometriosis-related malignant ovarian tumours (MT).

Methods

This retrospective study examined 19 lesions from SMBT and 84 lesions from MT. The following quantitative values were evaluated using receiver-operating characteristic analysis: overall and solid portion sizes, fluid signal intensity (SI), degree of contrast-enhancement, and mean and minimum apparent diffusion coefficient (ADC) values of the solid portion. Two radiologists independently evaluated four MRI findings characteristic of SMBT, fluid SI on the T1-weighted image and SI of the solid portion on diffusion-weighted image. The diagnostic values of these findings and interobserver agreement were assessed.

Results

For diagnosing SMBT, the mean ADC value of the solid portion showed the greatest area under the curve (0.860) (cut-off value: 1.31 × 10-3 mm2/s, sensitivity: 1.00, specificity: 0.61). The T2-weighted image (T2WI) high SI solid portion was the most useful finding, with high specificity and interobserver agreement (sensitivity, 0.58; specificity, 0.95–0.96, kappa = 0.96), followed by T2WI low SI core (sensitivity, 0.48–0.63; specificity, 0.98, kappa = 0.68).

Conclusion

Mean ADC values of the solid portion, T2WI high SI solid portion, and T2WI low SI core were useful for differentiating SMBT from MT.

Key Points

SMBT is a newly categorised ovarian tumour often associated with endometriosis.
Differentiation of SMBT from endometriosis-related malignant ovarian tumour is clinically important.
Diagnostic performances of quantitative values and MRI findings were evaluated.
Mean ADC value of the solid portion was the most useful value.
“T2WI high SI solid portion” was the most useful MRI finding.
Literatur
1.
Zurück zum Zitat Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014) WHO classification of tumours of female reproductive organs. International Agency for Research on Cancer, Lyon Kurman RJ, Carcangiu ML, Herrington CS, Young RH (2014) WHO classification of tumours of female reproductive organs. International Agency for Research on Cancer, Lyon
2.
Zurück zum Zitat Taylor J, McCluggage WG (2015) Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm. Am J Surg Pathol 39:983–992CrossRefPubMed Taylor J, McCluggage WG (2015) Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm. Am J Surg Pathol 39:983–992CrossRefPubMed
3.
Zurück zum Zitat Rutgers JL, Scully RE (1988) Ovarian Mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer 61:340–348CrossRefPubMed Rutgers JL, Scully RE (1988) Ovarian Mullerian mucinous papillary cystadenomas of borderline malignancy. A clinicopathologic analysis. Cancer 61:340–348CrossRefPubMed
4.
Zurück zum Zitat Kim KR, Choi J, Hwang JE et al (2010) Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation. Histopathology 57:587–596CrossRefPubMed Kim KR, Choi J, Hwang JE et al (2010) Endocervical-like (Müllerian) mucinous borderline tumours of the ovary are frequently associated with the KRAS mutation. Histopathology 57:587–596CrossRefPubMed
5.
Zurück zum Zitat Yoshikawa H, Jimbo H, Okada S et al (2000) Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 50:11–17CrossRefPubMed Yoshikawa H, Jimbo H, Okada S et al (2000) Prevalence of endometriosis in ovarian cancer. Gynecol Obstet Invest 50:11–17CrossRefPubMed
6.
7.
Zurück zum Zitat Wu CH, Mao T-L, Vang R et al (2012) Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol 31:297–303CrossRefPubMedPubMedCentral Wu CH, Mao T-L, Vang R et al (2012) Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A. Int J Gynecol Pathol 31:297–303CrossRefPubMedPubMedCentral
8.
Zurück zum Zitat Shappell HW, Riopel MA, Smith Sehdev AE et al (2002) Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 26:1529–1541CrossRefPubMed Shappell HW, Riopel MA, Smith Sehdev AE et al (2002) Diagnostic criteria and behavior of ovarian seromucinous (endocervical-type mucinous and mixed cell-type) tumors: atypical proliferative (borderline) tumors, intraepithelial, microinvasive, and invasive carcinomas. Am J Surg Pathol 26:1529–1541CrossRefPubMed
9.
Zurück zum Zitat Rodriguez IM, Irving JA, Prat J (2004) Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol 28:1311–1318CrossRefPubMed Rodriguez IM, Irving JA, Prat J (2004) Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases. Am J Surg Pathol 28:1311–1318CrossRefPubMed
10.
Zurück zum Zitat Coumbos A, Sehouli J, Chekerov R et al (2009) Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany. Br J Cancer 100:1731–1738CrossRefPubMedPubMedCentral Coumbos A, Sehouli J, Chekerov R et al (2009) Clinical management of borderline tumours of the ovary: results of a multicentre survey of 323 clinics in Germany. Br J Cancer 100:1731–1738CrossRefPubMedPubMedCentral
11.
12.
Zurück zum Zitat Lalwani N, Shanbhogue AKP, Vikram R et al (2010) Current update on borderline ovarian neoplasms. Am J Roentgenol 194:330–336CrossRef Lalwani N, Shanbhogue AKP, Vikram R et al (2010) Current update on borderline ovarian neoplasms. Am J Roentgenol 194:330–336CrossRef
13.
Zurück zum Zitat Seidman JD, Cho KR, Ronnett BM, Kurman RJ (2011) Surface epithelial tumors of the ovary. In: Blaustein’s Pathol. Female Genit. Tract. Springer US, Boston, MA, pp 679–784 Seidman JD, Cho KR, Ronnett BM, Kurman RJ (2011) Surface epithelial tumors of the ovary. In: Blaustein’s Pathol. Female Genit. Tract. Springer US, Boston, MA, pp 679–784
14.
Zurück zum Zitat Sugiyama T, Kamura T, Kigawa J et al (2000) Clinical characteristics of clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584–2589CrossRefPubMed Sugiyama T, Kamura T, Kigawa J et al (2000) Clinical characteristics of clear cell carcinoma of the ovary: A distinct histologic type with poor prognosis and resistance to platinum-based chemotherapy. Cancer 88:2584–2589CrossRefPubMed
15.
Zurück zum Zitat Matsubayashi RN, Matsuo Y, Nakazono T et al (2015) Magnetic resonance imaging manifestations of ovarian Mullerian mixed epithelial borderline tumors: imaging and histologic features in comparison with Mullerian mucinous borderline tumors. J Comput Assist Tomogr 39:276–280CrossRefPubMed Matsubayashi RN, Matsuo Y, Nakazono T et al (2015) Magnetic resonance imaging manifestations of ovarian Mullerian mixed epithelial borderline tumors: imaging and histologic features in comparison with Mullerian mucinous borderline tumors. J Comput Assist Tomogr 39:276–280CrossRefPubMed
16.
Zurück zum Zitat Kataoka M, Togashi K, Koyama T et al (2002) MR imaging of müllerian mucinous borderline tumors arising from endometriotic cysts. J Comput Assist Tomogr 26:532–537CrossRefPubMed Kataoka M, Togashi K, Koyama T et al (2002) MR imaging of müllerian mucinous borderline tumors arising from endometriotic cysts. J Comput Assist Tomogr 26:532–537CrossRefPubMed
17.
Zurück zum Zitat Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed Kanda Y (2013) Investigation of the freely available easy-to-use software “EZR” for medical statistics. Bone Marrow Transplant 48:452–458CrossRefPubMed
18.
Zurück zum Zitat Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed Landis JR, Koch GG (1977) The measurement of observer agreement for categorical data. Biometrics 33:159–174CrossRefPubMed
19.
Zurück zum Zitat Namimoto T, Awai K, Nakaura T et al (2009) Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 19:745–760CrossRefPubMed Namimoto T, Awai K, Nakaura T et al (2009) Role of diffusion-weighted imaging in the diagnosis of gynecological diseases. Eur Radiol 19:745–760CrossRefPubMed
20.
Zurück zum Zitat Punwani S (2011) Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Eur J Radiol 78:21–29CrossRefPubMed Punwani S (2011) Diffusion weighted imaging of female pelvic cancers: concepts and clinical applications. Eur J Radiol 78:21–29CrossRefPubMed
21.
Zurück zum Zitat Zhao SH, Qiang JW, Zhang GF et al (2014) Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation. Eur Radiol 24:2292–2299CrossRefPubMed Zhao SH, Qiang JW, Zhang GF et al (2014) Diffusion-weighted MR imaging for differentiating borderline from malignant epithelial tumours of the ovary: pathological correlation. Eur Radiol 24:2292–2299CrossRefPubMed
22.
Zurück zum Zitat Fujii S, Kakite S, Nishihara K et al (2008) Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging 28:1149–1156CrossRefPubMed Fujii S, Kakite S, Nishihara K et al (2008) Diagnostic accuracy of diffusion-weighted imaging in differentiating benign from malignant ovarian lesions. J Magn Reson Imaging 28:1149–1156CrossRefPubMed
23.
Zurück zum Zitat Thomassin-Naggara I, Daraï E, Cuenod CA et al (2009) Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 19:1544–1552CrossRefPubMed Thomassin-Naggara I, Daraï E, Cuenod CA et al (2009) Contribution of diffusion-weighted MR imaging for predicting benignity of complex adnexal masses. Eur Radiol 19:1544–1552CrossRefPubMed
24.
Zurück zum Zitat Takeuchi M, Matsuzaki K, Nishitani H (2010) Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr 34:173–176CrossRefPubMed Takeuchi M, Matsuzaki K, Nishitani H (2010) Diffusion-weighted magnetic resonance imaging of ovarian tumors: differentiation of benign and malignant solid components of ovarian masses. J Comput Assist Tomogr 34:173–176CrossRefPubMed
25.
Zurück zum Zitat Li W, Chu C, Cui Y et al (2012) Diffusion-Weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging 37:897–903CrossRefPubMed Li W, Chu C, Cui Y et al (2012) Diffusion-Weighted MRI: a useful technique to discriminate benign versus malignant ovarian surface epithelial tumors with solid and cystic components. Abdom Imaging 37:897–903CrossRefPubMed
26.
Zurück zum Zitat Siegelman ES, Oliver ER (2012) MR Imaging of endometriosis: ten imaging pearls. Radiographics 32:1675–1691CrossRefPubMed Siegelman ES, Oliver ER (2012) MR Imaging of endometriosis: ten imaging pearls. Radiographics 32:1675–1691CrossRefPubMed
27.
Zurück zum Zitat Tanaka YO, Okada S, Yagi T et al (2010) MRI of endometriotic cysts in association with ovarian carcinoma. Am J Roentgenol 194:355–361CrossRef Tanaka YO, Okada S, Yagi T et al (2010) MRI of endometriotic cysts in association with ovarian carcinoma. Am J Roentgenol 194:355–361CrossRef
28.
Zurück zum Zitat Burdette JH, Elster AD, Ricci PE (1999) Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 212:333–339CrossRefPubMed Burdette JH, Elster AD, Ricci PE (1999) Acute cerebral infarction: quantification of spin-density and T2 shine-through phenomena on diffusion-weighted MR images. Radiology 212:333–339CrossRefPubMed
29.
Zurück zum Zitat Thomassin-Naggara I, Daraï E, Cuenod CA et al (2008) Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 28:111–120CrossRefPubMed Thomassin-Naggara I, Daraï E, Cuenod CA et al (2008) Dynamic contrast-enhanced magnetic resonance imaging: a useful tool for characterizing ovarian epithelial tumors. J Magn Reson Imaging 28:111–120CrossRefPubMed
Metadaten
Titel
Diagnostic performance of MR imaging findings and quantitative values in the differentiation of seromucinous borderline tumour from endometriosis-related malignant ovarian tumour
verfasst von
Yasuhisa Kurata
Aki Kido
Yusaku Moribata
Kyoko Kameyama
Yuki Himoto
Sachiko Minamiguchi
Ikuo Konishi
Kaori Togashi
Publikationsdatum
23.08.2016
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 4/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-016-4533-x

Weitere Artikel der Ausgabe 4/2017

European Radiology 4/2017 Zur Ausgabe

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.